BDBM260155 US9522910, Table 1 Compound 5: 4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-(2-{[1,2,4]triazolo[4,3-b]pyridazin-3-yl}ethynyl)benzamide
SMILES CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3nnc4cccnn34)cc2C(F)(F)F)CC1
InChI Key InChIKey=KWRIGWZQRBNVJT-UHFFFAOYSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 260155
TargetTyrosine-protein kinase ABL1 [T315I](Homo sapiens (Human))
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
US Patent
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
US Patent
Affinity DataIC50: <20nMAssay Description:Kinase activity and inhibition was measured by established protocols (see e.g. Braunwalder et al., A Solid-Phase Assay for the Determination of Prote...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
US Patent
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
US Patent
Affinity DataIC50: <20nMAssay Description:Kinase activity and inhibition was measured by established protocols (see e.g. Braunwalder et al., A Solid-Phase Assay for the Determination of Prote...More data for this Ligand-Target Pair